FORT LAUDERDALE, Fla., Aug. 31, 2017 -- OmniComm Systems, Inc. (OmniComm) (OTCQX:OMCM), a global leading provider of clinical data management technology, today announced that it has received certification approval from the U.S. Department of Commerce for the EU-U.S. Privacy Shield Framework program and the Swiss-U.S. Privacy Shield Framework, the successors to the U.S.-EU and U.S.-Swiss Safe Harbor Frameworks.
“This is an important achievement,” said Djuro Blanuscha, OmniComm Europe GmbH’s data protection officer. “We have made great efforts to implement the high European data protection standards throughout the entire company, and we will continue to work to ensure compliance with the related regulations in the future.”
The U.S. Department of Commerce and the European Commission developed the EU-U.S. Privacy Shield and the Swiss-U.S. Privacy Shield Frameworks “to provide companies on both sides of the Atlantic with a mechanism to comply with data protection requirements when transferring personal data from the European Union and Switzerland to the United States in support of transatlantic commerce,” according to a statement from the Privacy Shield program.
The Privacy Shield has replaced the U.S.-EU Safe Harbor Program, which was invalidated in October of 2015. More information about the Privacy Shield can be found at: https://www.privacyshield.gov
“OmniComm values and respects the confidentiality and the protection of personal data. With our commitment to comply with Privacy Shield requirements, we assure our European clients and partners that their personal information is handled in adherence to the strict European data privacy principles when it is transferred to the U.S.,” said Yvonne Rollinger, Ph.D., managing director of OmniComm Europe GmbH.
About OmniComm Systems, Inc.
OmniComm Systems, Inc. is a leading strategic software solutions provider to the life sciences industry. OmniComm is dedicated to helping the world’s pharmaceutical, biotechnology, contract research organizations, diagnostic and device firms, and academic medical centers maximize the value of their clinical research investments. Through the use of innovative and progressive technologies, these organizations drive efficiency in clinical development, better manage their risks, ensure regulatory compliance and manage their clinical operations performance. With an extensive global experience from more than 5,000 clinical trials, OmniComm provides comprehensive solutions for clinical research. For more information, visit: www.omnicomm.com
Trademarks
OmniComm, TrialMaster, TrialOne, and Promasys are registered trademarks of OmniComm Systems, Inc. Other names may be trademarks of their respective owners.
Contact Info Kuno van der Post OmniComm Systems, Inc. +1.954.473.1254 [email protected]


Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Elon Musk’s SpaceX Acquires xAI in Historic Deal Uniting Space and Artificial Intelligence
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Ford and Geely Explore Strategic Manufacturing Partnership in Europe 



